Return to search

MTS recaps Trumpet Behavioral Health

MTS Health Investors has recapitalized Trumpet Behavioral Health, a provider of behavioral health services to children and adults with Autism Spectrum Disorder and developmental disabilities. No financial terms were disclosed. Triple-Tree served as financial adviser to Trumpet on the transaction.


NEW YORK–(BUSINESS WIRE)–MTS Health Investors, LLC (“MTS”), the New York-based healthcare private equity firm, announced that funds managed by MTS have completed a recapitalization of Trumpet Behavioral Health, LLC (“Trumpet” or the “Company”). Trumpet is a leading provider of behavioral health services, specializing in the treatment of children, adolescents, and adults with Autism Spectrum Disorder (“ASD”) and developmental disabilities, using the principles of Applied Behavior Analysis (“ABA”). Trumpet’s ABA therapy is delivered by therapists under the supervision of Board Certified Behavior Analysts. The Company currently has over 950 team members, providing therapy in over 25 locations across 8 states.

MTS has partnered with Trumpet’s existing senior management team to recapitalize the business and to provide additional capital to support future growth. Terms of the transaction were not disclosed.

Lani Fritts, Trumpet’s Chief Executive Officer, commented, “MTS’s investment, coupled with their operational resources and deep understanding of Autism and healthcare services, will be incredibly valuable as we continue to expand and enhance our services. Our partnership with MTS represents an important milestone in helping us live our mission and values every day and positively impact the individuals we serve.”

“We are thrilled to be partnering with Trumpet’s talented leadership team,” said CJ Burnes, Principal with MTS. “The Trumpet team has built a clear market leader in ABA therapy with a national reputation for providing the highest level of clinical care. We look forward to supporting the Company’s continued growth.”

MTS Senior Managing Director, Oliver T. Moses, said, “MTS has spent a significant amount of time evaluating the autism landscape and is pleased to be investing in a market that has tremendous tailwinds and that is improving the lives of children. We feel fortunate to be partnering with a premier platform with an exceptional clinical record in this dynamic industry. MTS’s investment in Trumpet is emblematic of MTS’s strategy to proactively identify market leaders in targeted health care industry sectors.”

Triple-Tree acted as financial advisor to Trumpet. Bartlit Beck Herman Palenchar & Scott LLP acted as legal advisor to Trumpet, and McDermott Will & Emery LLP acted as legal advisor to MTS.

About Trumpet Behavioral Health
Trumpet Behavioral Health offers evidenced-based behavioral health services to children and adults with Autism Spectrum Disorder and other developmental disabilities based on the principles of Applied Behavior Analysis. A team of over 950 passionate and highly-skilled individuals, including numerous Ph.D. and Masters-level Board Certified Behavior Analysts and Board Certified Assistant Behavior Analysts, provides center-based, school-based and in-home services throughout Arizona, California, Colorado, Hawaii, Illinois, Kansas, Ohio and Texas. For more information please visit

About MTS
MTS Health Investors, LLC (“MTS”) makes equity investments in companies that operate within the services sectors of the healthcare industry. We focus on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. MTS manages over $700 million in investments and is currently investing out of its fourth fund. We are based in New York City and invest in companies throughout the United States.
For more information, please email us at